Combating the Opioid Crisis

WASHINGTON, DC - Energy and Commerce Committee Republican Leader Greg Walden (R-OR) and Judiciary Committee Republican Leader Doug Collins (R-GA) applauded House passage of S. 3201, the temporary extension on the fentanyl analogues ban.

For weeks, Walden and Collins have pushed Democratic leadership to pass this extension after Democrats objected to its inclusion in the spending bill. Without this extension, the ban on fentanyl analogues would expire on February 6, making these drugs essentially street legal.

“There is no question that fentanyl poses an absolutely deadly threat to American lives, yet...

WASHINGTON, DC – Energy and Commerce Committee Republican Leader Greg Walden (R-OR) remarks at an Oversight and Investigations Subcommittee hearing, titled – “A Public Health Emergency: State Efforts to Curb the Opioid Crisis” – where we will be conducting oversight of states' utilization of federal funding to combat the opioid crisis.

As Prepared for Delivery

Madam Chair, thank you for holding this critically important hearing.

For many years, the Energy and Commerce Committee—and this Subcommittee in particular—has been at the forefront of the Congressional effort to address the opioid crisis, as well as substance...

WASHINGTON, DC – Energy and Commerce Committee Republican Leader Greg Walden (R-OR), Oversight and Investigations Subcommittee Republican Leader Brett Guthrie (R-KY), and Representative Morgan Griffith (R-VA) are renewing an investigation into the role of top opioid manufacturers in the ongoing opioid crisis. In letters to Insys Therapeutics, Mallinckrodt Pharmaceuticals, and Purdue Pharma, the lawmakers press for further answers from the manufacturers to an August 2018 inquiry into the three manufacturers.

"We are continuing our work investigating the causes and effects of the opioid epidemic. Last Congress, the Committee on Energy...